Cilazapril/Hydrochlorothiazide

西拉普利/氢氯噻嗪

Report date: 2022/01/14 13:23:58

Base Information

Drug NameCilazapril/Hydrochlorothiazide
Drug Alias NameCilazapril-Hydrochlorothiazide西拉普利氢氯噻嗪氢氯噻嗪-西拉普利Cilazapril and HydrochlorothiazideCilazapril•Hydrochlorothiazide +[10] 
ClassificationSmall molecules
Mechanisms of ActionThiazide-sensitive sodium-chloride cotransporter inhibitorsAngiotensin-converting enzyme inhibitors
TargetsThiazide-sensitive sodium-chloride cotransporterAngiotensin-converting enzyme
Therapy Area/IndicationsHypertension
Global Approved IndicationsHypertension
Approved Indications in ChinaN/A
Original Approved Country/TerritoryItaly
Original Approved Date1997/01/01
Country/TerritoryItaly
CombinationsYes HydrochlorothiazideCilazapril
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesF. Hoffmann-La Roche Ltd
China Registration ClassN/A

Develop Information

Active CompaniesF. Hoffmann-La Roche Ltd
Inactive CompaniesN/A
Active IndicationsHypertension
Inactive IndicationsN/A

Other Information

ATC CodeC09BA08
Related LinksN/A